# BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients

> **NCT04501341** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 15 (estimated)

## Conditions studied

- T2D

## Interventions

- **BIOLOGICAL:** Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC
- **BIOLOGICAL:** Intravenous Infusion of UC-MSC

## Key facts

- **NCT ID:** NCT04501341
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03-14
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04501341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04501341, "BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04501341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*